21 May 2009
Pentoxifylline augments fasting induced nephroprotection in ischemic model of acute kidney injury in rats
A Wystrychowski, W Wystrychowski, P Król, E Obuchowicz, L Cierpka, A WięcekAnn Transplant 2009; 14(1): 60-60 :: ID: 880418
Abstract
Background: Ischemic acute kidney injury (iAKI) activates also general inflammatory reaction. Prolonged fasting exerts anti-inflammatory effects through increased secretion of ghrelin - an orexigenic hormone produced in the gastrointestinal system that inhibits NF-B activation and induces IL-10 release. PTX has similar immunomodulating and anti-inflammatory properties. The aim of this study was to assess and compare the influence of feeding status and PTX administration on the course of iAKI.
Material/Methods: 44 male Sprague-Dawley rats, 14 days after right nephrectomy and 7 days before renal ischemia were placed in individual cages preventing feaces consumption with ad libitum water access. Rats of groups Ia and Ib were fed with no limitations as opposed to groups IIa and IIb, starved for 32 hours prior to renal ischemia. 90 min before left kidney vascular pedicle clamping (for 45 min) rats of groups Ib/IIb and Ia/IIa were given PTX (100 mg/kg body weight in 1ml 0.9% NaCl, s.c.) or 0.9% NaCl only, respectively. Creatinine clearance (CrCl; ml/min/kg bw), fractional excretion of sodium (FENa; %) and proteinuria to creatinine clearance ratio (PUrea/ClCrea) were estimated 24 hours after ischemia.
Results: As shown in the table, both fasting and PTX administration diminished the degree of ischemia-induced impairment of renal function. Their combined effects were additive.
Conclusions: Fasting and treatment with pentoxifylline in the periischemic period exert additive nephroprotective effects in the setting of ischemic acute kidney injury. These findings may be useful in the studies and future practice of preservation of kidney transplant function.
Keywords: Ischemia reperfusion injury, Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






